ArticleJournal of managed care & specialty pharmacy2023

Descriptive, real-world treatment patterns, resource use, and total cost of care among eculizumab- and ravulizumab-treated members with paroxysmal nocturnal hemoglobinuria.

Kelly C Broderick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.